PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.85 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,478,000 | -59.3% | 152,351 | -57.2% | 0.02% | -57.1% |
| Q2 2018 | $3,629,000 | -69.9% | 355,740 | -61.7% | 0.05% | -70.7% |
| Q1 2018 | $12,066,000 | +80.3% | 928,148 | +148.2% | 0.17% | +81.5% |
| Q4 2017 | $6,693,000 | -22.2% | 373,900 | +9.1% | 0.09% | -27.6% |
| Q3 2017 | $8,598,000 | – | 342,561 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |